![]() |
市場調査レポート
商品コード
1753911
血管内加温システム市場レポート:製品タイプ、医療専門分野、用途、エンドユーザー、地域別、2025~2033年Intravascular Warming Systems Market Report by Product Type, Medical Specialty, Application, End User (Operating Rooms, Intensive Care Units, Emergency Rooms, and Others), and Region 2025-2033 |
||||||
カスタマイズ可能
|
血管内加温システム市場レポート:製品タイプ、医療専門分野、用途、エンドユーザー、地域別、2025~2033年 |
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2~3営業日
|
血管内加温システムの世界市場規模は2024年に1億5,320万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに1億9,480万米ドルに達し、2025~2033年の成長率(CAGR)は2.57%を示すと予測しています。外科手術の普及とヘルスケア産業の進歩が市場成長を刺激しています。
精密温度制御への需要の高まり
血管内加温システムは、患者の体温を正確に管理することで、医療介入における精度のニーズの高まりに対応します。この動向は、さまざまなヘルスケア環境において患者の安全性を高め、転帰を改善することが求められていることに起因しています。例えば、2024年3月、ZOLLはThermogardとIQoolシステムを搭載した先進的な血管内加温システムを発表しました。これらの技術革新は、体内カテーテルと体外パッドを介して患者の体温を管理し、体幹温度と体表温度を効果的にコントロールすることにより、精度と患者の転帰を改善します。血管内加温システム市場分析レポートによると、これは重要な成長促進要因として作用しています。
クリティカルケア現場での採用増加
正常体温を維持し、低体温を予防するために、クリティカルケアでの血管内加温システムの使用が増加しています。この動向は、患者の転帰を改善し、重篤な状態での合併症を減らすための体温管理の重要性を反映しており、血管内加温システム市場の需要を高めています。例えば、2024年3月には、CHILL-SHOCK検査が心原性ショック(CS)患者における標的体温管理(TTC)の安全性を評価しました。この検査では、転帰を改善し、CSに関連する高い死亡率に対処するための補助療法の可能性について血管内加温システムが検討されました。
加温システムの技術的進歩
血管内加温技術の革新は、より優れたコントロール、効率、安全性を記載しています。このような進歩は、より効果的な患者治療をサポートし、全体的な治療の質を向上させるために医療機器を改善することに重点を置くヘルスケア産業と一致しています。例えば、2024年1月、カリフォルニア工科大学は、抗生物質やその他の化学的抗菌方法を必要とせずに、細菌の上流への移動を妨げる新しいタイプのカテーテルチューブを設計しました。
The global intravascular warming systems market size reached USD 153.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 194.8 Million by 2033, exhibiting a growth rate (CAGR) of 2.57% during 2025-2033. The increasing prevalence of surgical procedures and advancements in the healthcare industry are stimulating the market growth.
Growing Demand for Precision Temperature Control
Intravascular warming systems enable accurate management of patient temperatures, thereby addressing the increasing need for precision in medical interventions. This trend is driven by the requirement to enhance patient safety and improve outcomes in various healthcare settings. For example, in March 2024, ZOLL introduced advanced intravascular warming systems featuring the Thermogard and IQool systems. These innovations manage patient temperature via internal catheters and external pads, thereby improving precision and patient outcomes by controlling core and surface temperatures effectively. According to the intravascular warming systems market analysis report, this is acting as a significant growth-inducing factor.
Rising Adoption in Critical Care Settings
There is a growing use of intravascular warming systems in critical care to maintain normothermia and prevent hypothermia. This trend reflects the importance of temperature management in improving patient outcomes and reducing complications during critical conditions, thereby elevating the intravascular warming systems market demand. For instance, in March 2024, the CHILL-SHOCK trial assessed the safety of targeted temperature control (TTC) in cardiogenic shock (CS) patients. This study explored intravascular warming systems as potential adjunct therapies to improve outcomes and address high mortality rates associated with CS.
Technological Advancements in Warming Systems
Innovations in intravascular warming technology provide better control, efficiency, and safety. These advancements support more effective patient care and align with the healthcare industry's focus on improving medical devices to enhance overall treatment quality. For example, in January 2024, Caltech designed a new type of catheter tube that impedes the upstream mobility of bacteria without the need for antibiotics or other chemical antimicrobial methods.
According to the intravascular warming systems market forecast report, the segment is driven by the rising requirement for maintaining patient temperature. Convective warming tubing is favored in critical care settings for its efficiency. Water bath warming systems are traditional and widely used, providing consistent heat but with bulkier setups. Heat block warming systems offer precise temperatures.
Intravascular warming systems are crucial across various medical fields, including cardiology, neurology, oncology, orthopedics, and general surgery. They regulate patient temperature during procedures, enhancing safety and outcomes by preventing hypothermia and optimizing therapeutic effectiveness in these diverse specialties.
Perioperative care dominates the intravascular warming systems market share
Perioperative care leads the intravascular warming systems market due to its critical role in maintaining patient normothermia during surgery. Effective temperature management prevents complications like hypothermia, ensuring safer procedures and improved recovery outcomes, driving demand for advanced warming technologies in the operating room.
Operating rooms dominate the market
Operating rooms dominate the intravascular warming systems market, with devices like the arctic sun providing essential temperature regulation during surgeries. This helps ensure patient safety and reduces hypothermia-related complications, thereby leading to their widespread use in surgical settings. This is positively influencing the intravascular warming systems market outlook across the segmentation.
North America dominates the market
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
According to the intravascular warming systems market outlook report, North America dominates the market driven by advanced healthcare infrastructure and high adoption rates. For instance, systems like the Arctic Sun and Thermogel are extensively used in U.S. hospitals to maintain optimal patient temperatures during surgery. The region's focus on improving surgical outcomes and patient safety further solidifies its dominance, supported by substantial investments in medical technology and growing awareness of hypothermia risks.